ALIROCUMAB

25752 reported adverse events

Drug classes: PCSK9 Inhibitor [EPC]

These side effects are most commonly reported by patients taking ALIROCUMAB:

# Side effect Count
0 MYALGIA 1710
1 INJECTION SITE PAIN 1406
2 PRODUCT DOSE OMISSION 1363
3 MUSCLE SPASMS 1209
4 ARTHRALGIA 1088
5 FATIGUE 1054
6 PAIN 979
7 PAIN IN EXTREMITY 959
8 PRODUCT DOSE OMISSION ISSUE 926
9 INJECTION SITE BRUISING 905
See all common reactions for ALIROCUMAB

ALIROCUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 127 0.7095
1 SKIN PRESSURE MARK 85 0.4009
2 URTICARIA CONTACT 9 0.2500
3 ADMINISTRATION SITE INDENTATION 12 0.1935
4 PRODUCT DELIVERY MECHANISM ISSUE 608 0.1130
5 MYOGLOBIN BLOOD INCREASED 130 0.0850
6 LOW DENSITY LIPOPROTEIN DECREASED 116 0.0818
7 OBSTRUCTIVE SLEEP APNOEA SYNDROME 113 0.0775
8 APPLICATION SITE INJURY 14 0.0737
9 LOW DENSITY LIPOPROTEIN ABNORMAL 34 0.0555
See all enriched reactions for ALIROCUMAB